- Email: [email protected]
5406881 Apparatus for a dealcoholizing plant
PATENT ABSTRACTS Vitamin B 12 compounds, salts and pharmaceutical compositions containing said compounds represented by formula (I): (*See Patent for Chemical Structure*) (I) CH3HCOOOPORBCH2NH wherein L, a ligand to the cobalt of the corrin ring, is selected from the group consisting of a cyano or adenosyl group, B is an imidazole group or a 5,6-dimethylbenzimidazole group, and R is a straight alkylene group having 1 to 8 carbon atoms, are disclosed. Methods for preparing compounds of Formula (I) as well as methods for using the compounds in in vitro assays, in cell growth studies and in in vivo studies using transplanted marine tumor cells are disclosed.
5405942 PREPRO INSULIN-LIKE GROWTH FACTORS I AND H Bell Graeme I; Rail Leslie B; Merryweather James P San Francisco, CA, UNITED STATES Assigned to Chiron Corporation Polynucleotide sequences which encode for human prepro insulin-like growth factors are provided. Such sequences are obtained from the human genome, typically by screening a eDNA library obtained from human liver cells. The polynucleotide sequences may be used for cloning and expression of insulin-like growth factors in suitable hosts, as well as for the production of DNA and RNA which may be used as hybridization probes. E. coli strains HB 101 (phigfl) and HB 101 (phigf2) were deposited at the ATCC on Jun. 8, 1984, and granted accession nos. 39729 and 39730, respectively.
5405943 TOURETTE SYNDROM, AUTISM AND ASSOCIATED BEHAVIORS Comings David E Duarte, CA, UNITED STATES Assigned to City of Hope The human tryptophan oxygenase gene sequence and chromosomal location are described. Procedures for the diagnosis of genetic Tourette syndrome and many psychiatric and behavioral disorders by genetic tests to identify deletions or defective alleles in the human tryptophan
209
oxygenase (TO) gene and eDNA probes for use in such tests are also described.
5406881 APPARATUS FOR A DEALCOHOLIZING Petershans Horst; Komer Bittenfeld, GERMANY
PLANT Rudolf
7050
In known beverage dealcoholizing plants, one disadvantage is that volatile content materials always escape, and the end product consequently lacks aroma materials and/or preserving materials that were previously present. This disadvantage is eliminated in that the volatile content materials, previously lost into the surroundings via the vacuum pump, are fed back again into the beverage. A duct at the exhaust air pipe, connected to the vacuum pump and leading to a gas washer, circulates the volatile content materials back into the beverage.
5407545 METHOD FOR MEASURING SAMPLE BY ENZYME ELECTRODES Hirose Kazunor Kyoto, JAPAN Assigned to Kyoto Daiichi Kagaku Co Ltd A buffer solution is charged in a reaction container so that enzyme electrodes can be immersed in the buffer solution. Current values between the enzyme electrodes, to which a voltage is applied, are sampled at predeterminedtime intervals. A decreasing curve of current is predicted on the basis of the sampled current values. A sample is injected in said buffer solution at an early time before the current between enzyme electrodes become stable, whereby oxidation reaction of a specified component of the sample is caused. A current value I1 between enzyme electrodes is measured and simultaneously a current value T2 on the decreasing curve is obtained at a point that a predetermined time passes from the sample injection point to obtain a current increase from the sample injection on the basis of a difference of the current values I1 and 12. A quantity of the specified component of the sample is obtained on the basis of the current increase.
5405942 PREPRO INSULIN-LIKE GROWTH FACTORS I AND H Bell Graeme I; Rail Leslie B; Merryweather James P San Francisco, CA, UNITED STATES Assigned to Chiron Corporation Polynucleotide sequences which encode for human prepro insulin-like growth factors are provided. Such sequences are obtained from the human genome, typically by screening a eDNA library obtained from human liver cells. The polynucleotide sequences may be used for cloning and expression of insulin-like growth factors in suitable hosts, as well as for the production of DNA and RNA which may be used as hybridization probes. E. coli strains HB 101 (phigfl) and HB 101 (phigf2) were deposited at the ATCC on Jun. 8, 1984, and granted accession nos. 39729 and 39730, respectively.
5405943 TOURETTE SYNDROM, AUTISM AND ASSOCIATED BEHAVIORS Comings David E Duarte, CA, UNITED STATES Assigned to City of Hope The human tryptophan oxygenase gene sequence and chromosomal location are described. Procedures for the diagnosis of genetic Tourette syndrome and many psychiatric and behavioral disorders by genetic tests to identify deletions or defective alleles in the human tryptophan
209
oxygenase (TO) gene and eDNA probes for use in such tests are also described.
5406881 APPARATUS FOR A DEALCOHOLIZING Petershans Horst; Komer Bittenfeld, GERMANY
PLANT Rudolf
7050
In known beverage dealcoholizing plants, one disadvantage is that volatile content materials always escape, and the end product consequently lacks aroma materials and/or preserving materials that were previously present. This disadvantage is eliminated in that the volatile content materials, previously lost into the surroundings via the vacuum pump, are fed back again into the beverage. A duct at the exhaust air pipe, connected to the vacuum pump and leading to a gas washer, circulates the volatile content materials back into the beverage.
5407545 METHOD FOR MEASURING SAMPLE BY ENZYME ELECTRODES Hirose Kazunor Kyoto, JAPAN Assigned to Kyoto Daiichi Kagaku Co Ltd A buffer solution is charged in a reaction container so that enzyme electrodes can be immersed in the buffer solution. Current values between the enzyme electrodes, to which a voltage is applied, are sampled at predeterminedtime intervals. A decreasing curve of current is predicted on the basis of the sampled current values. A sample is injected in said buffer solution at an early time before the current between enzyme electrodes become stable, whereby oxidation reaction of a specified component of the sample is caused. A current value I1 between enzyme electrodes is measured and simultaneously a current value T2 on the decreasing curve is obtained at a point that a predetermined time passes from the sample injection point to obtain a current increase from the sample injection on the basis of a difference of the current values I1 and 12. A quantity of the specified component of the sample is obtained on the basis of the current increase.